A recent budget document prepared by the White House is giving new clarity over how the Department of Health and Human ...

The Trump administration's fiscal 2026 budget-in-brief for the U.S. Department of Health and Services cuts deeply into some ...

HHS has proposed oversight of the 340B drug pricing program to the Centers for Medicare & Medicaid Services as part of a broader reorganization.  The move, initially referenced in a preliminary memo ...

A budget proposal for the US Department of Health and Human Services details extensive cuts to funding for the National ...

President Donald Trump’s proposed fiscal 2026 budget slashes funding for the National Institutes of Health by $18 billion to $27.5 billion as part of a sweeping overhaul to realign federal healthcare ...

The Health and Human Services Department would look a lot different, and spend a lot less money, under a plan the White House ...

The HHS said it has taken the first step toward implementing most-favored-nation pricing for prescription drugs.

On April 22, 2025, the US Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) announced a series of ...

The Food and Drug Administration (FDA) has approved Moderna's next-generation COVID-19 vaccine, mNEXSPIKE, for specific ...

The funding was meant to help the U.S. prepare for pandemics triggered by avian flu strains, but now leaves the future of ...

While the CDC typically relies on a panel of vaccine experts to make public health recommendations, this process was skipped in making the COVID-19 recommendation.

Pharmaceutical rivals don’t often come to each other’s defense. But after the US Department of Health and Human Services ...